Anna Katherine Krawisz, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 7 | 2023 | 1188 | 2.080 |
Why?
|
Endarterectomy, Carotid | 2 | 2021 | 546 | 1.090 |
Why?
|
Endovascular Procedures | 3 | 2023 | 1979 | 0.970 |
Why?
|
Carotid Stenosis | 2 | 2021 | 854 | 0.940 |
Why?
|
Femoral Artery | 4 | 2023 | 845 | 0.900 |
Why?
|
Popliteal Artery | 3 | 2021 | 317 | 0.860 |
Why?
|
Coated Materials, Biocompatible | 2 | 2021 | 319 | 0.830 |
Why?
|
Intermittent Claudication | 1 | 2021 | 309 | 0.650 |
Why?
|
Paclitaxel | 3 | 2021 | 1707 | 0.600 |
Why?
|
Drug-Eluting Stents | 2 | 2021 | 753 | 0.580 |
Why?
|
Angioplasty, Balloon | 1 | 2021 | 653 | 0.570 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 882 | 0.510 |
Why?
|
Cardiovascular Agents | 1 | 2021 | 850 | 0.490 |
Why?
|
Healthcare Disparities | 3 | 2023 | 3158 | 0.370 |
Why?
|
Vascular Patency | 2 | 2021 | 886 | 0.320 |
Why?
|
Atherectomy | 1 | 2023 | 47 | 0.230 |
Why?
|
Stroke | 2 | 2021 | 9981 | 0.210 |
Why?
|
Limb Salvage | 1 | 2022 | 433 | 0.180 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2375 | 0.170 |
Why?
|
Stents | 2 | 2021 | 3280 | 0.170 |
Why?
|
DiGeorge Syndrome | 1 | 2020 | 177 | 0.170 |
Why?
|
Treatment Outcome | 6 | 2023 | 63119 | 0.140 |
Why?
|
Hypolipidemic Agents | 1 | 2021 | 604 | 0.140 |
Why?
|
Angioplasty | 1 | 2019 | 364 | 0.140 |
Why?
|
Calcium Signaling | 1 | 2020 | 721 | 0.140 |
Why?
|
Medicare | 3 | 2023 | 6566 | 0.130 |
Why?
|
United States | 6 | 2024 | 69867 | 0.110 |
Why?
|
Risk Factors | 5 | 2024 | 72280 | 0.110 |
Why?
|
Self Tolerance | 1 | 2013 | 125 | 0.110 |
Why?
|
Risk Assessment | 3 | 2021 | 23337 | 0.100 |
Why?
|
Patient Discharge | 1 | 2024 | 3313 | 0.100 |
Why?
|
Chromosome Disorders | 1 | 2013 | 515 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3305 | 0.090 |
Why?
|
Health Status Disparities | 1 | 2020 | 1797 | 0.080 |
Why?
|
Thymus Gland | 1 | 2013 | 1267 | 0.080 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2008 | 55 | 0.080 |
Why?
|
Humans | 14 | 2024 | 744220 | 0.080 |
Why?
|
Neurons | 2 | 2020 | 9335 | 0.080 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.080 |
Why?
|
Aged | 5 | 2023 | 163253 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5316 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2023 | 77426 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 2014 | 0.070 |
Why?
|
Registries | 1 | 2021 | 8090 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13990 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2020 | 5709 | 0.060 |
Why?
|
Synapses | 1 | 2013 | 1729 | 0.060 |
Why?
|
Female | 9 | 2023 | 380197 | 0.060 |
Why?
|
Male | 7 | 2023 | 350027 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15538 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2013 | 4385 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2023 | 57768 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 20945 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2013 | 3690 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4465 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11728 | 0.040 |
Why?
|
Tubulin Modulators | 1 | 2019 | 110 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2013 | 1877 | 0.040 |
Why?
|
Transcription Factors | 2 | 2013 | 12207 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1223 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 700 | 0.030 |
Why?
|
GABA Agents | 1 | 2013 | 42 | 0.030 |
Why?
|
Extremities | 1 | 2019 | 865 | 0.030 |
Why?
|
Receptors, Glutamate | 1 | 2013 | 232 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2013 | 351 | 0.030 |
Why?
|
Adult | 2 | 2022 | 214035 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2013 | 844 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 501 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2020 | 11478 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7148 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 973 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1736 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1526 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2013 | 1475 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2013 | 1401 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2013 | 1284 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2013 | 1179 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1602 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10396 | 0.020 |
Why?
|
Lymphocyte Depletion | 1 | 2008 | 608 | 0.020 |
Why?
|
Pluripotent Stem Cells | 1 | 2013 | 795 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10387 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2513 | 0.020 |
Why?
|
Autoimmunity | 1 | 2013 | 1349 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7730 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1987 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7659 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 25043 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9960 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3250 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9735 | 0.010 |
Why?
|
Mice | 3 | 2013 | 81178 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15999 | 0.010 |
Why?
|
Trans-Activators | 1 | 2008 | 2924 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 213367 | 0.010 |
Why?
|
Animals | 3 | 2013 | 168788 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12075 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4477 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56436 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2008 | 5853 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14556 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 21824 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23404 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18027 | 0.010 |
Why?
|
Child | 1 | 2013 | 77679 | 0.000 |
Why?
|